About
- Accomplished and pragmatic leader with over 25 years of experience building and…
Activity
-
New pharmacology training videos on the Pharmechanics YouTube channel! Interested in GPCR signaling pharmacology? These videos explain why the data…
New pharmacology training videos on the Pharmechanics YouTube channel! Interested in GPCR signaling pharmacology? These videos explain why the data…
Liked by Marc Navre
-
I am deeply honored and thrilled to share that I have been appointed Affiliate Associate Professor in the Department of Pharmaceutical Sciences…
I am deeply honored and thrilled to share that I have been appointed Affiliate Associate Professor in the Department of Pharmaceutical Sciences…
Liked by Marc Navre
-
Extremely well deserved praise for one of the most impressive women I've ever had the fortune to know, much less work with. Under Caroline Winnett's…
Extremely well deserved praise for one of the most impressive women I've ever had the fortune to know, much less work with. Under Caroline Winnett's…
Liked by Marc Navre
Experience
Education
More activity by Marc
-
I'm honored and thrilled to be named to this year's @Forbes' 50 Over 50 list in #Innovation! I join a list of extraordinary women created in…
I'm honored and thrilled to be named to this year's @Forbes' 50 Over 50 list in #Innovation! I join a list of extraordinary women created in…
Liked by Marc Navre
-
SkyDeck Alumni, Hayden AI, just announced their $90M Series C! It's been amazing to see them grow from a couple of desks at SkyDeck to where they are…
SkyDeck Alumni, Hayden AI, just announced their $90M Series C! It's been amazing to see them grow from a couple of desks at SkyDeck to where they are…
Liked by Marc Navre
-
Super cool experience being able to speak about Berkeley SkyDeck on Bloomberg this morning. There's a lot of amazing things happening at Berkeley…
Super cool experience being able to speak about Berkeley SkyDeck on Bloomberg this morning. There's a lot of amazing things happening at Berkeley…
Liked by Marc Navre
-
Our CEO Raymond Stevens recently spoke with CNBC Fast Money's Melissa Lee to discuss our progress with our #GLP1 receptor agonist drug, GSBR-1290…
Our CEO Raymond Stevens recently spoke with CNBC Fast Money's Melissa Lee to discuss our progress with our #GLP1 receptor agonist drug, GSBR-1290…
Liked by Marc Navre
-
I was honored to present as a part of Biomed Israel 2024 last week discussing how to "Unlock Extra-Hepatic Delivery Using Machine Learning." Our work…
I was honored to present as a part of Biomed Israel 2024 last week discussing how to "Unlock Extra-Hepatic Delivery Using Machine Learning." Our work…
Liked by Marc Navre
-
Had a wonderful time meeting other GPs and LPs at Liquidity this past weekend. Jason Calacanis and the team at LAUNCH run a class act, and every…
Had a wonderful time meeting other GPs and LPs at Liquidity this past weekend. Jason Calacanis and the team at LAUNCH run a class act, and every…
Liked by Marc Navre
-
We're pleased to share positive topline data from our 12-week Phase 2a #obesity study of our oral, non-peptide GLP-1 receptor agonist, GSBR-1290…
We're pleased to share positive topline data from our 12-week Phase 2a #obesity study of our oral, non-peptide GLP-1 receptor agonist, GSBR-1290…
Liked by Marc Navre
-
We're pleased to share financial results and recent corporate achievements for the first quarter of 2024 as well as upcoming plans to share topline…
We're pleased to share financial results and recent corporate achievements for the first quarter of 2024 as well as upcoming plans to share topline…
Liked by Marc Navre
-
Have you registered already? We’re 11 days from the registration deadline for the Dr.GPCR University workshop “Advanced Data Analysis for GPCR…
Have you registered already? We’re 11 days from the registration deadline for the Dr.GPCR University workshop “Advanced Data Analysis for GPCR…
Liked by Marc Navre
-
Embarking on a new adventure - I'm beyond excited to join Amy Burroughs and our talented team at Terns Pharmaceuticals to build a remarkable company…
Embarking on a new adventure - I'm beyond excited to join Amy Burroughs and our talented team at Terns Pharmaceuticals to build a remarkable company…
Liked by Marc Navre
-
Today, we reported program updates and financial results for the fourth quarter and year ended December 31, 2023. Read the full press release here:…
Today, we reported program updates and financial results for the fourth quarter and year ended December 31, 2023. Read the full press release here:…
Liked by Marc Navre
-
The Department of Pathology at Stanford University is actively searching for an exceptional scientist to join us as an Assistant, Associate, or Full…
The Department of Pathology at Stanford University is actively searching for an exceptional scientist to join us as an Assistant, Associate, or Full…
Liked by Marc Navre
-
Thanks so much for your support Pier 70 Ventures! We are grateful for your support and excited for the future!
Thanks so much for your support Pier 70 Ventures! We are grateful for your support and excited for the future!
Liked by Marc Navre
-
Thank you #paloalto for this awesome recognition and thank you Clear Ventures for your amazing and consistent support (and also for being amazing…
Thank you #paloalto for this awesome recognition and thank you Clear Ventures for your amazing and consistent support (and also for being amazing…
Liked by Marc Navre
-
We are super grateful and honored to be a participant of this award by Biomedical Advanced Research and Development Authority (BARDA). BARDA’s…
We are super grateful and honored to be a participant of this award by Biomedical Advanced Research and Development Authority (BARDA). BARDA’s…
Liked by Marc Navre
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More